Synthetic Design Lab

Synthetic Design Lab is a clinical-stage biotechnology company founded in 2022 developing next-generation antibody-drug conjugates (ADCs) for cancer therapy. Its SYNTHBODY platform and SYNTHBODY Engine engineer multispecific biologics with layered BIO-LOGIC control mechanisms and targeted payload delivery reported at 10x or more versus conventional ADCs. The company emerged from stealth in April 2025 with a $20M seed round led by Playground Global and Godfrey Capital, and is led by CEO Daniel S. Chen (formerly Global Head of Cancer Immunotherapy Development at Genentech) and CSO Ramesh Baliga. This is a therapeutics research company with no public API, SDK, or developer surface at the time of enrichment.

Synthetic Design Lab is profiled on the APIs.io network. Tagged areas include Company, Engineered Biology, Biotechnology, Therapeutics, and Oncology.

🌐 Visit website 📡 Source on GitHub

6.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyEngineered BiologyBiotechnologyTherapeuticsOncologyAntibody-Drug ConjugatesDrug DiscoveryCancer

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 6.8/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/synthetic-design-lab: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: synthetic-design-lab
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/synthetic-design-lab.png
name: Synthetic Design Lab
description: Synthetic Design Lab is a clinical-stage biotechnology company founded in 2022 developing next-generation antibody-drug
  conjugates (ADCs) for cancer therapy. Its SYNTHBODY platform and SYNTHBODY Engine engineer multispecific biologics with
  layered BIO-LOGIC control mechanisms and targeted payload delivery reported at 10x or more versus conventional ADCs. The
  company emerged from stealth in April 2025 with a $20M seed round led by Playground Global and Godfrey Capital, and is led
  by CEO Daniel S. Chen (formerly Global Head of Cancer Immunotherapy Development at Genentech) and CSO Ramesh Baliga. This
  is a therapeutics research company with no public API, SDK, or developer surface at the time of enrichment.
url: https://raw.githubusercontent.com/api-evangelist/synthetic-design-lab/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- playground-global
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Engineered Biology
- Biotechnology
- Therapeutics
- Oncology
- Antibody-Drug Conjugates
- Drug Discovery
- Cancer
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.syntheticdesignlab.com/
x-enrichment:
  date: '2026-07-21'
  status: nochange
  artifacts_added: 0
  pass: local-v1